Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND)

European Journal of Human Genetics - Tập 12 Số 3 - Trang 241-244 - 2004
Ron Milo1, М. И. Шадрина2, P. A. Slominsky2, G. N. Levitsky1, E. I. Kondratieva2, A. L. Zherebtsova2, N. I. Levitskaya1, A. V. Alekhin1, A.V. Serdyuk1, Limborskaia Sa2
1Department of Fundamental and Clinical Neurology, Russian State Medical University, Lenskay str.15, block 3, Moscow, Russia
2Institute of Molecular Genetics, Russian Scientific Academy, Moscow, Russia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Nelson LM : Epidemiology of ALS. Clin Neurosci 1995; 3: 327–331.

Rosen DR, Siddique T, Patterson D et al: Mutation in CuZn-superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.

Scvortsova VI, Limborska PA, Slominsky PA et al: Sporadic ALS associated with the D90A CuZn-superoxide dismutase mutation in Russia. Eur J Neurol 2001; 8: 167–172.

Hirano A : Cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 91–101.

Figlewicz DA, Rouleau GA, Krizus A, Julien JP : Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene 1993; 132: 297–300.

Al-Chalabi Am, Andersen PM, Nilsson P et al: Deletions of neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157–164.

Julien J : Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 2001; 104: 581–591.

Brooks BR, Miller RG, Swash M, Munsat TL, Airlie House ‘Current Issues in ALS Therapeutic Trials’ Workshop Contributors: E1 Escorial revisted: revised criteria for the diagnosis of amyotrophic lateral sclerosis (1998), (The WFN/ALS Website).

Norris FH, Callachini PR, Fallat RG et al: Administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721–728.

Miller SA, Dykes DD, Polesky HF : A sample salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.

Figlewicz DA, Krizus A, Martinoli MG et al: Variants of the heavy neurofilament subunit are association with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757–1761.

Grasbon-Frodl EM, Kosel S, Reiss O et al: Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun 1999; 255: 749–752.

Hingorany AD, Sharma P, Jia H et al: Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28: 907–911.

Rigat B, Hubert C, Corvol P et al: FPCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1)(dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.

Hirano A, Donnefeld H, Sasaki S, Nakano I : Fine structural observation of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984; 43: 471–480.

Shaw CE, Enayat ZE, Powell JF et al: Familial amyotrophic lateral sclerosis. Molecular pathology of patient with a SOD1 mutation. Neurology 1997; 49: 1612–1616.

Julien JP, Cote F, Collard JF : Mice overexpressing the human neurofilament heavy gene as model of ALS. Neurobiol Aging 1995; 16: 487–490.

Xu Z, Cork LS, Griffing FW, Cleveland DW : Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993; 73: 23–33.

Al-Chalabi Am, Miller CCJ : Neurofilaments and neurological disease. BioEssays 2003; 24: 346–355.